View Future GrowthDeepak Chemtex 過去の業績過去 基準チェック /46Deepak Chemtexは、平均年間26%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.7% 7.4%収益成長率で 成長しています。 Deepak Chemtexの自己資本利益率は18.7%であり、純利益率は15.4%です。主要情報26.02%収益成長率19.76%EPS成長率Chemicals 業界の成長17.68%収益成長率7.35%株主資本利益率18.70%ネット・マージン15.42%次回の業績アップデート29 May 2026最近の業績更新お知らせ • May 22Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026お知らせ • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025お知らせ • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024すべての更新を表示Recent updatesお知らせ • May 22Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026New Risk • May 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year.New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year.New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year.お知らせ • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • Aug 26Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year.お知らせ • Jul 28Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025.Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year.New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m).Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year.Valuation Update With 7 Day Price Move • Dec 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.New Risk • Dec 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m).Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India.お知らせ • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024お知らせ • Aug 30Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024.Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India.Reported Earnings • Jun 05Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023)Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India.お知らせ • May 17Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India.New Risk • Apr 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m).Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India.Buying Opportunity • Dec 14Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%.Board Change • Dec 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Deepak Chemtex の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BSE:544036 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費30 Sep 2571811157030 Jun 2575711755031 Mar 2579712453031 Dec 2473310446030 Sep 246688543030 Jun 245837239031 Mar 244976035031 Mar 234676127031 Mar 225414224031 Mar 2129626190質の高い収益: 544036 非現金収入 のレベルが高いです。利益率の向上: 544036の現在の純利益率 (15.4%)は、昨年(12.7%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 544036の収益は過去 5 年間で年間26%増加しました。成長の加速: 544036の過去 1 年間の収益成長率 ( 30.3% ) は、5 年間の平均 ( 年間26%を上回っています。収益対業界: 544036の過去 1 年間の収益成長率 ( 30.3% ) はChemicals業界11%を上回りました。株主資本利益率高いROE: 544036の 自己資本利益率 ( 18.7% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 20:05終値2026/05/26 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Deepak Chemtex Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 22Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026
お知らせ • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025
お知らせ • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • May 22Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026
New Risk • May 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year.
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year.
New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year.
お知らせ • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • Aug 26Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year.
お知らせ • Jul 28Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025.
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year.
New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m).
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year.
Valuation Update With 7 Day Price Move • Dec 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.
New Risk • Dec 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m).
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India.
お知らせ • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • Aug 30Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024.
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India.
Reported Earnings • Jun 05Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023)Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India.
お知らせ • May 17Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India.
New Risk • Apr 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m).
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India.
Buying Opportunity • Dec 14Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%.
Board Change • Dec 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.